Market News
Stay updated with the latest market trends, earnings, and economic indicators.
Death in a vial: Five cases lay bare many uncomfortable truths about Indian healthcare
Five young mothers in Kota died after childbirth, with suspicion falling on oxytocin injections. Investigations revealed the vials contained only water, not the active ingredient. The manufacturer, Jackson Laboratories, has had stop-production orders earlier as well. This incident has put focus on critical failures in drug regulation and raises serious concerns about patient safety.
India needs innovation at scale to fulfill ambition of becoming global discovery hub: Dr Reddy's
India must shift from minor advancements to large-scale innovation to become a global discovery hub, according to Dr. Reddy's Laboratories Chairman Satish Reddy. He emphasized the need for robust translational research pathways to ensure scientific breakthroughs benefit patients. The company's white paper highlights that stronger collaboration between academia, industry, and government is crucial for translating research into accessible healthcare solutions and overcoming existing challenges.
Six pharma stocks that should be on your radar today over various news triggers
It was a busy weekend for pharma stocks as four of them — Divi's Laboratories, Fortis Healthcare, Torrent Pharma and Narayana Hrudayalaya — reported their quarterly results. Meanwhile, Lupin marked its entry into the Chinese market, while Glenmark Pharma's US arm settled an anti-trust litigation. Here's a look at these names in detail:
Caplin Steriles receives USFDA approval for Foscarnet Sodium Injection
Caplin Steriles (CSL), a subsidiary company of Caplin Point Laboratories has been granted final approval from the United States Food and Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Foscarnet Sodium Injection (6000 mg/250 mL Infusion Bag), a generic therapeutic equivalent version of the Reference Listed Drug (RLD) Foscavir Injection from Clinigen Healthcare, (NDA 020068).
Unique Picks: 6 stocks held by only one MF scheme in April, falling up to 40% in CY26
An analysis of mutual fund portfolios revealed 29 stocks held exclusively by single schemes, with most underperforming in CY26. However, Satin Creditcare Network, Rossell Techsys, and Amanta Healthcare bucked the trend, delivering strong returns. Brooks Laboratories and EFC (I) were among those experiencing significant declines.
Explained | Here's why Dr Reddy's Laboratories shares have recovered 3% from their day's lows
Dr Reddy's said the US SEC has concluded its investigation into the anonymous allegations of improper payments to healthcare professionals in Ukraine and potentially other markets, possibly violating the US Foreign Corrupt Practices Act. Meanwhile, Citi has a 'sell' rating on the stock on the back of Novo Nordisk's aggression when it comes to protecting and expanding volumes of generic semgalutide.
Closing Bell: Nifty crosses 24,200, Sensex surges 1,264 pts on renewed hopes of US-Iran peace talks
Interglobe Aviation, Max Healthcare, Power Grid Corp, Wipro, Eternal were among biggest gainers on the Nifty, while losers were Dr Reddy's Laboratories, Bharti Airtel, ICICI Bank. All the sectoral indices ended in the green with Capital Goods, Oil & Gas, Power, Infra, Media, Realty, Consumer Durables, IT rise 2% each. Nifty Midcap and Smallcap indices up more than 2 percent each.
Taking Stock: Nifty ends above 24,200, Sensex up 1,264 points; all sectors rally
Interglobe Aviation, Max Healthcare, Power Grid Corp, Wipro, Eternal were among biggest gainers on the Nifty, while losers were Dr Reddy's Laboratories, Bharti Airtel, ICICI Bank.